PAROVEN Capsule Ref.[8610] Active ingredients: Rutoside Troxerutin

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2020  Publisher: Thornton & Ross Ltd., Linthwaite, Huddersfield, HD7 5QH, UK

Therapeutic indications

Relief of symptoms of oedema associated with chronic venous insufficiency.

Posology and method of administration

Posology

Adults and elderly

2 capsules (500mg) twice daily.

Patients with heart, renal or hepatic impairment

Patients who have oedema of the lower limbs due to heart, kidney or liver disease should not use Paroven because the effect of O-(beta-hydroxyethyl)-rutosides has not been shown in these indications.

Paediatric population

The safety and efficacy of Paroven in children and adolescents aged less than 18 years has not yet been established. No data are available.

Method of administration

Oral use.

Overdose

No cases of overdosage with symptoms have been reported. No specific antidotes are known.

Shelf life

60 months.

Special precautions for storage

Protect from moisture.

Nature and contents of container

Blister pack composed of PVC blisters sealed with aluminium foil.

Blister pack composed of PVC/PE/PVDC blisters sealed with aluminium foil.

Pack sizes: 120 capsules.

Special precautions for disposal and other handling

Keep this medicine out of the sight and reach of children.

No special requirements for disposal.

Any unused product or waste material should be disposed of in accordance with local requirements.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.